In recent years, with the development and maturity of AI technologies such as image recognition and natural language processing, as well as emerging technologies such as 5G, Internet of Things, and cloud computing, and with the strong support and encouragement of national policies, the smart medical industry has entered a new era of development.
In this regard, Yu Yigang said that in the era of intelligence, simulation technology is playing an active and key role. In the digital economy 100 list (Digital 100) released by Forbes, ADI, which is known for its high-performance analog technology, is on the list. With the continuous penetration of intelligence in the medical field, analog signal chain products based on various high-performance sensors are playing an increasingly critical role in the wave of medical intelligence, and analog technology has ushered in a broader space for development.
And with the advancement of digital technology, the demand for high-precision, high-speed, low-power analog products continues to expand, and analog products largely determine the performance of today’s digital devices. “The development of industries such as cloud computing, big data, and artificial intelligence is promoting the implementation of medical intelligence. In the era of digital economy with computing power as the core, analog technology and devices play an indispensable role in connecting the real world with A key bridge role in the digital world.
ADI has been deeply involved in the field of medical electronics for decades, and has always deeply integrated leading analog technology with the medical industry. Facing a new round of technological revolution, relying on its core technology advantages, it insists on responding to the ever-changing industry with innovation. Talking about the development status of China’s medical electronics market and the challenges it faces, Yu Yigang believes that low power consumption, diagnostic-level performance, high integration/small size, and short design cycle are the current challenges in physical signal monitoring equipment. To this end, ADI provides complete system-level solutions and reference designs, and a dedicated technical team provides system-level professional support and technical services.
In the medical imaging detection category, such as X-ray flat panel detectors, the design challenges are: lower X-ray dose, fast dynamic images, portability, and reduction of design cycles. The challenges faced by CT are: more slices (16 slices -> 64 slices -> 128 slices -> 320 slices), lower X-ray dose, lower system cost, and shortened time to market. ADI provides higher channel count, complete signal chain, lower power consumption, faster, lower noise integrated subsystem, competitive cost and coherent roadmap, with a dedicated team of experts to provide system-level application support, Help customers overcome challenges and accelerate design-to-launch time.
ADI’s above products and solutions are not a single generation of products, but a series of products with strategic planning, the purpose is to lead the market development trend as much as possible, solve the user’s system-level application problems and comprehensively improve the end-user experience. Therefore, we continue to improve performance and cost optimization, thereby consolidating the market position of the double-sided advantage of cost performance. Of course, there are different relative performance comparison conclusions for different application scenarios, specific design goals, and differences in the user’s discriminating conditions. Typically, our new products have at least a 1/3 or more improvement in overall performance over the previous generation, and in most cases we can achieve greater performance. For pioneering products, the performance improvement that can usually help the manufacturer of the whole machine will be more significant. Of course, we usually don’t bring system-level cost increases to users while improving overall performance.
ADI is very optimistic about the prospects of technology and business in the medical field, will continue to focus strategically, and actively participate in relevant seminars and invest in related technology and product development. In fact, ADI’s own medical business team already has biomedical experts to help the entire team provide better solutions to customers. In addition, we also have local technical experts who have a deep understanding of medical regulations, and they will work with customers to complete the design challenges of performance and reliability in all relevant medical standards. And a considerable-scale software development team, as well as third-party partners, will provide a full range of solutions for software, hardware and system-level applications.
ADI hopes that through its own continuous investment, together with our customers, we can help the ultimate patient (or user) and physician to solve the problems they face, such as measurement accuracy, ease of use, cost and reliability. We also hope that with the unremitting efforts of our customers, we can break through the boundaries of existing product forms in terms of business models and product application forms. Challenges such as “distribution of medical resources”, “graded diagnosis and treatment” and “improvement of primary medical facilities” have made their own industry contributions.
ADI will continue to work with partners in the whole ecological chain from prevention, diagnosis, treatment, and disease management with an open mind to jointly promote the technological development of China’s medical industry and help to achieve the goal of “Healthy China” of people’s health and longevity.